Drawing for BLINDSPOT

USPTO serial 99669208

BLINDSPOT

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MICHELI, ANGELA M
Law office
TMEG LAW OFFICE 101

What this means

Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose. Watch for publication (status 686) and monitor the 30-day opposition window.

Status 680: Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose.

Need help with BLINDSPOT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
035Technology-enabled business consulting and management in the field of clinical trials, namely, clinical trial planning, business project and program management, operational management, workflow management, information and data management, quality management, regulatory information management, safety event management, and management and compilation of computerized databases for business purposes; business intelligence, business data analysis, market research and market intelligence services, including AI-enabled analysis, risk identification, decision support and generation of business insights, relating to clinical research and clinical trial operations for the life science industry, medical device companies, clinical research organizations and academic research organizations.ACTIVE—
042Providing online non-downloadable software for the design, planning, implementation, execution, project management and operational management of clinical trials, including workflow management, data management, quality management, regulatory information management, safety event management and business analytics, for the life science industry, medical device companies, clinical research organizations and academic research organizations; providing online non-downloadable software using artificial intelligence (AI) for business analytics, data analysis, risk identification, decision support and generation of insights relating to clinical research and clinical trial operations.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 2, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 22, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 22, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 22, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 28, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Sep 28, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jun 29, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 29, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 29, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 24, 2026DOCKASSIGNED TO EXAMINER—
Jun 23, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 25, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 25, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance